No Data
No Data
Shanghai MicroPort EP MedTech Co., Ltd. (SHSE:688351) Shares Could Be 25% Above Their Intrinsic Value Estimate
Shanghai MicroPort EP MedTech Forecasts Up to 828% Surge in H1 Attributable Profit
Voluntary disclosure announcement of the 2024 semi-annual performance forecast.
Microdiagnostics (688351.SH): Net profit in the first half of 2024 is expected to increase by 595.92% year-on-year to 827.89%.
On July 4th, Gelunhui reported that MicroElectroPhysiology(688351.SH) expects to achieve revenue of 195 million yuan to 210 million yuan in the first half of 2024, an increase of 52.88 million yuan to 67.88 million yuan, or 37.21% to 47.76% year-on-year. The net income attributable to the owner of the parent company is expected to be 15 million yuan to 20 million yuan.
Cathay Pacific Junan: The valuation level of the normalized mining industry is expected to rise
The Zhitong Finance App learned that Guotai Junan released a research report saying that in recent years, the quality of collection has been improved and expanded. Along with this, the design of collection rules has been continuously improved, and the results are more moderate and predictable. The results of this joint China Mining contract renewal have provided further verification. As the negative effects of traditional product collection are gradually clarified, emerging varieties are rapidly being admitted to hospital through collection. The number of surgeries is expected to continue to grow under the combined impetus of factors such as an aging population, increased public health awareness, and more mature procedures. The high-value consumables industry is also expected to continue to flourish on a new base, and the industry's valuation level is expected to rise. Maintain Elken Healthcare (0178
Microelectronic Physiology (688351.SH): Net profit of 4.169 million yuan in the first quarter
On April 25, Ge Longhui (688351.SH) released its first quarter report. Operating revenue was 89.15 million yuan, up 71.01% year on year, net profit of 4.169 million yuan, after deducting non-net loss of 1.35 million yuan, and basic earnings per share of 0.0089 yuan.
No Data